SCOPUS 정보 검색 플랫폼

Clinical Drug Investigation

Volumn 16, Issue 2, 1998, Pages 111-116

Assessment of HPA-Axis suppression with fluticasone cream 0.05% in patients with extensive psoriasis or eczema

(2) Tschen, Eduardo H a Bucko, Alicia D a

a Academic Dermatology Associates (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUTICASONE; HYDROCORTISONE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BLOOD CHEMISTRY; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG TOLERABILITY; ECZEMA; FEMALE; HEMATOLOGY; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; HYDROCORTISONE URINE LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSORIASIS; TOPICAL DRUG ADMINISTRATION; URINALYSIS;

EID: 0031705774 PISSN: 11732563 EISSN: None Source Type: Journal
DOI: 10.2165/00044011-199816020-00003 Document Type: Article

Times cited : (8)

References (14)

1
- 0029061925
- Fluticasone propionate in the treatment of inflammatory dermatoses
- Chu AC, Munn S. Fluticasone propionate in the treatment of inflammatory dermatoses. Br J Clin Pract 1995; 49: 131-3
- (1995) Br J Clin Pract , vol.49 , pp. 131-133
- Chu, A.C.¹ Munn, S.²

2
- 0025132348
- The human pharmacology of fluticasone propionate
- Harding SM. The human pharmacology of fluticasone propionate. Respir Med 1990; 84 Suppl. A: 25-9
- (1990) Respir Med , vol.84 , Issue.SUPPL. A , pp. 25-29
- Harding, S.M.¹

3
- 0030076243
- Fluticasone propionate: Safety profile
- Johnson M. Fluticasone propionate: safety profile. Cutis 1996; 57 Suppl.; 10-2
- (1996) Cutis , vol.57 , Issue.SUPPL. , pp. 10-12
- Johnson, M.¹

4
- 0030078329
- Topical steroids in clinical practice: Focus on fluticasone propionate
- Piacquadio DJ. Topical steroids in clinical practice: focus on fluticasone propionate. Cutis 1996; 57 Suppl.: 4-9
- (1996) Cutis , vol.57 , Issue.SUPPL. , pp. 4-9
- Piacquadio, D.J.¹

5
- 0030078233
- Comparison of safety and efficacy of fluticasone propionate cream, 0.05%, and betamethasone valerate cream. 0.1%, in the treatment of moderate-to-severe psoriasis
- Callen J. Comparison of safety and efficacy of fluticasone propionate cream, 0.05%, and betamethasone valerate cream. 0.1%, in the treatment of moderate-to-severe psoriasis. Cutis 1996; 57 Suppl.: 45-50
- (1996) Cutis , vol.57 , Issue.SUPPL. , pp. 45-50
- Callen, J.¹

6
- 0025092716
- Structure-activity relationships of topically active steroids: The selection of fluticasone propionate
- Phillipps GH. Structure-activity relationships of topically active steroids: the selection of fluticasone propionate. Respir Med 1990; 84 Suppl. A: 19-23
- (1990) Respir Med , vol.84 , Issue.SUPPL. A , pp. 19-23
- Phillipps, G.H.¹

7
- 0027959815
- Binding kinetics of fluticasone propionate to the human glucocorticoid receptor
- Hugger P, Rohdewald P. Binding kinetics of fluticasone propionate to the human glucocorticoid receptor. Steroids 1994; 59: 597-602
- (1994) Steroids , vol.59 , pp. 597-602
- Hugger, P.¹ Rohdewald, P.²

8
- 0027416428
- The new corticosteroids: Are they safe and effective?
- Degreef H, Dooms-Goossens A. The new corticosteroids: are they safe and effective? Dermatol Clin 1993; 11: 155-60
- (1993) Dermatol Clin , vol.11 , pp. 155-160
- Degreef, H.¹ Dooms-Goossens, A.²

9
- 0001909183
- A comparison of the systemic absorption of fluticasone propionate and betamethasone valerate after topical application of cream formulations
- Young MMR, Sohail S, Harding SM. A comparison of the systemic absorption of fluticasone propionate and betamethasone valerate after topical application of cream formulations [abstract]. Br J Dermatol 1994; 131 Suppl. 44: 35-6
- (1994) Br J Dermatol , vol.131 , Issue.44 SUPPL. , pp. 35-36
- Young, M.M.R.¹ Sohail, S.² Harding, S.M.³

10
- 0030076934
- Efficacy and safety of fluticasone propionate, 0.005% ointment in the treatment of psoriasis
- Olsen EA. Efficacy and safety of fluticasone propionate, 0.005% ointment in the treatment of psoriasis. Cutis 1996; 57 Suppl.: 57-61
- (1996) Cutis , vol.57 , Issue.SUPPL. , pp. 57-61
- Olsen, E.A.¹

11
- 0030076216
- A comparison of the safety, tolerability, and efficacy of fluticasone propionate ointment, 0.005%, and betamethasone-17,21-dipropionate ointment, 0.05%, in the treatment of eczema
- Delescluse J, van der Endt JD. A comparison of the safety, tolerability, and efficacy of fluticasone propionate ointment, 0.005%, and betamethasone-17,21-dipropionate ointment, 0.05%, in the treatment of eczema. Cutis 1996; 57 Suppl.: 32-8
- (1996) Cutis , vol.57 , Issue.SUPPL. , pp. 32-38
- Delescluse, J.¹ Van Der Endt, J.D.²

12
- 0030078082
- Efficacy and safety of fluticasone propionate ointment, 0.005%, in the treatment of eczema
- Lebwohl M. Efficacy and safety of fluticasone propionate ointment, 0.005%, in the treatment of eczema. Cutis 1996; 57 Suppl.: 62-8
- (1996) Cutis , vol.57 , Issue.SUPPL. , pp. 62-68
- Lebwohl, M.¹

13
- 0030076217
- Comparison of fluticasone propionate cream, 0.05%, and hydrocortisone-17-butyrate cream, 0.1%, in the treatment of eczema
- Juhlin L. Comparison of fluticasone propionate cream, 0.05%, and hydrocortisone-17-butyrate cream, 0.1%, in the treatment of eczema. Cutis 1996; 57 Suppl.: 51-6
- (1996) Cutis , vol.57 , Issue.SUPPL. , pp. 51-56
- Juhlin, L.¹

14
- 0030075998
- Comparison of fluticasone propionate ointment, 0.005%, and betamethasone-17,21-dipropionate ointment, 0.05%, in the treatment of psoriasis
- Roberts DT. Comparison of fluticasone propionate ointment, 0.005%, and betamethasone-17,21-dipropionate ointment, 0.05%, in the treatment of psoriasis. Cutis 1996; 57 Suppl.: 27-31
- (1996) Cutis , vol.57 , Issue.SUPPL. , pp. 27-31
- Roberts, D.T.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.